Accuracy of urine NGAL commercial assays in critically ill patients

Matthieu Legrand(University of California, San Francisco), Didier Payen(Délégation Paris 7), V. Giraudeaux(Université Paris Cité), Étienne Gayat(Inserm), Jean‐Marie Launay(Université Claude Bernard Lyon 1), Corinne Collet(Northwestern University), Joaquim Matéo(Délégation Paris 5), Juliana Henao(Université Paris Cité)

Intensive Care Medicine

December 14, 2012

10.1007/s00134-012-2788-5

Cited by 14

Related Papers

Sepsis in European intensive care units: Results of the SOAP study*

|Critical Care Medicine|2006|2.9k

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

|The Lancet|2022|1k

A positive fluid balance is associated with a worse outcome in patients with acute renal failure

|Critical Care|2008|954

Sequential-Design, Multicenter, Randomized, Controlled Trial of Early Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction (DECIMAL Trial)

|Stroke|2007|867

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

|Nature Reviews Nephrology|2020|703